CNC vs TERN · P/E 8.4, rev $163.07B vs $6.12B cap
Centene Corp (CNC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CNC and TERN stock pages for the full models.
Not investment advice.